HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Newsfeed
Reload this Page Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Adva
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 09-20-2010, 05:11 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,959
Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In Adva
Boehringer Ingelheim announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer...

More...
News is offline   Reply With Quote
Old 09-20-2010, 04:54 PM   #2
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: Boehringer Ingelheim Initiates Phase III Clinical Trial With Novel Oral Agent In
I figured this was a weight loss med. Sounds encouraging..another oral HER tool.
__________________

Mom's treatment history (link)
Rich66 is offline   Reply With Quote
Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -7. The time now is 06:28 PM.
Contact Us - HER2 Support Group - Archive - Privacy Statement - Top

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter